Baidu
map

2021年10月23日简报:本轮本土疫情波及10省市,因为冷冻食品和动物可传播,源头追踪变得困难和复杂;欧亚多国疫情猛烈反弹,新冠新变种病毒AY 4.2.快速扩散,新一波疫情迹象出现;罗氏新冠药物合作方宣布新冠口服II期临床研究失败

2021-10-23 MedSci整理 MedSci整理

截至北京时间2021年10月23日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4370万例,新增447,168例,达到243,700,

截至北京时间2021年10月23日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过2亿4370万例,新增447,168例,达到243,700,643例。累计死亡病例495.2万例,达到4,952,792例。新增死亡为7,620例。康复为220,830,653例,重症和危重症病人达到76,394例;全球新冠确诊病例超过100万例的国家达36个,111个国家病例超10万例。昨日报道:2021年10月22日简报:中方共向一百多个国家和国际组织提供超过十五亿剂新冠疫苗;美国批准全部三种新冠疫苗作为加强剂

本轮本土疫情波及10省市,因为冷冻食品和动物可传播,源头追踪变得困难和复杂;欧亚多国疫情猛烈反弹,新冠新变种病毒AY 4.2.快速扩散,新一波疫情迹象出现;罗氏新冠药物合作方宣布新冠口服II期临床研究失败,为疫情控制蒙上阴影。

新冠病毒可以通过冷冻食品和动物传播,让疫情来源追踪变得十分复杂

本轮国内疫情波及10省市,不过因为旅行团疫苗接种都是比较高的,因此,未出现超级传播者。但是疫情源头则成谜。

事实上,新冠病毒的传播十分复杂,可以通过冷冻食品传播,也可以通过动物传播。目前有十数种动物可以携带新冠病毒,包括家庭常见的猫,狗,以及众多野生动物。这些动物一旦感染新冠病毒,很容易实现跨境传播,进一步可能会再次传染给人类的可能,使得病毒源头追踪变得异常复杂。

由于本轮疫情并没有国外接触者,因此,仅仅在人群中进行溯源,可能很难发现病毒的源头。

本轮疫情波及10省市,没有出现超级传播者

10月21日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例43例。其中境外输入病例15例(云南4例,广西3例,上海2例,山东2例,辽宁1例,河南1例,广东1例,陕西1例),含1例由无症状感染者转为确诊病例(在河南);本土病例28例(内蒙古11例,其中阿拉善盟10例、锡林郭勒盟1例;甘肃9例,其中兰州市5例、张掖市3例、嘉峪关市1例;陕西3例,均在西安市;宁夏2例,其中吴忠市1例、银川市1例;北京1例,在丰台区;贵州1例,在遵义市;青海1例,在海东市)。无新增死亡病例。无新增疑似病例。

据不完全统计,本轮疫情已经波及陕西、宁夏、内蒙古、甘肃、湖南、贵州、北京、河北、湖北、青海等10个省区市。尽管目前还不能完全明确感染来源,但旅行团传染链涉及的重点区域——内蒙古阿拉善盟额济纳旗已出现了多名确诊病例。

金冬雁表示,本轮疫情也基本符合新冠病毒的转播特点,“中招”的基本是共同游玩、共同居住或处于同一空间的密切接触者,目前并没有发现超级传播现象,疫情规模应该较为有限。

北京昨天新增6例京外关联本地新冠肺炎确诊病例

10月22日0时至24时,北京新增6例京外关联本地新冠肺炎确诊病例(其中病例1至病例4昨日已通报),无新增疑似病例和无症状感染者;无新增境外输入确诊病例、疑似病例和无症状感染者。

罗氏新冠药物合作方宣布新冠口服II期临床研究失败,股价暴跌70%

10 月 19 日,Atea Pharmaceuticals(NASDAQ:AVIR)公布了其在研新冠口服药——AT-527 的全球 II 期 MOONSONG 研究中,针对院外轻至中度 COVID-19 患者亚组人群的顶线结果。AT-527 治疗(550 mg, bid)组总体人群第 29 天 SARS-CoV-2 病毒载量较基线的变化与安慰剂组相比,并未明显降低,仍有大约 2/3 的患者属于伴有症状的低住院风险患者。因此,未能到达研究的主要终点。

有业内专家认为,本次试验的失败可能是招募了过多轻度甚至接种过疫苗的患者,最终导致与对照组相比,差异并不显著。Atea 首席执行官 Jean-Pierre Sommadossi 也表示,Atea 和罗氏正在根据新结果 “评估后期研究的潜在调整方向”。然而,投资者似乎对此并不买账。

此消息一出,美股 Atea 暴跌 65.96%。

资料显示,AT -527 (RO7496998) 为一种 RNA 聚合酶抑制剂,进入人体后可转化为游离碱 AT-511 (抗新冠病毒 EC90 达到 0.47 μM),随后生成抗新冠病毒活性更高的三磷酸代谢产物 AT-9010,体外抗新冠病毒活性较默沙东的口服新冠药 Molnupiravir 高 5-8 倍。

俄罗斯单日新增确诊新冠感染病例突破3.7万

俄罗斯新冠疫情防控指挥部22日发布的数据显示,过去24小时全俄新增确诊新冠病毒感染病例首次超过3.7万,达到37141例,新增死亡病例1064例,均为疫情暴发以来最高值。截至目前,全俄累计确诊新冠感染病例8168305例,累计死亡228453例,累计治愈7117060例。

为防止疫情进一步扩散,俄教科部新闻处22日发文称,10月30日至11月7日全俄带薪休假期间,各大高校可以采取远程教学模式,或为学生自主学习提供一定程度的方法指导并进行知识检测。日前,俄教育部已建议中小学在此期间全面停止教学工作,其中包括远程教学。

欧洲新冠新变种病毒AY 4.2.扩散中,以色列报警,英国和俄罗斯均发现

以色列卫生部表示,国内已证实出现一起先前若干欧洲国家通报的COVID-19(2019冠状病毒疾病)Delta变异株的亚变异株(subvariant)病例。

以色列卫生部昨天晚间透过声明表示:“在欧洲几个国家境内发现的AY 4.2.变异株,已经在以色列现踪。”

卫生部指出,带有这种病毒的是一名从欧洲入境的11岁男童,还说这起病例是在特拉维夫(Tel Aviv)班古里昂机场(Ben Gurion Airport)发现。

AY 4.2.变异株已数度在英国现踪。专家表示,AY.4.2的传染性似乎比原始的德尔塔变体高出10%到15%。

俄罗斯消费者权益保护和公益监督局中央流行病学研究所人类疾病诊断新方法研发科学小组负责人卡米勒哈菲佐夫表示,在俄罗斯个别病例中发现新冠毒株德尔塔的变种AY4.2,存在在俄罗斯广泛传播的可能。

美国疾病控制和预防中心(CDC)主任罗谢尔·瓦伦斯基(Rochelle Walensky)在周三的新闻发布会上证实,美国已发现AY.4.2。

欧亚多国疫情猛烈反弹

据俄媒21日报道,俄罗斯过去24小时新增确诊和死亡病例均创下新高,分别达到36339例和1036例。

英国在放松防疫措施后,疫情近期也出现急剧恶化的趋势。据英国《每日电讯报》、CNN等媒体报道,在过去两周,英国近50万人感染新冠病毒。仅在周一,英国的确诊病例就接近5万例,超过了法国、德国、意大利和西班牙的总和。周二,英国公布的单日死亡人数达到223人,这是自3月初以来的最高数字。在住院病例增加的情况下,一些英国医院再次濒临崩溃。

乌克兰政府21日数据显示,该国单日新增确诊病例创疫情暴发以来的新高,达到22415例。保加利亚正在经历今年4月以来最严重的疫情危机。该国周二的新增感染人数达到3246人,是一周前的两倍多。斯洛伐克卫生部周三公布的数据显示,该国的单日新增确诊病例达到3月9日以来的新高,为3480例。波兰卫生部长周三表示,该国出现了病例“爆炸”。21日,波兰政府公布的单日新增感染人数超过5000人,是5月以来的首次。

新加坡疫情也不容乐观。新加坡《联合早报》21日报道称,新加坡20日公布的单日死亡病例达到18例,是疫情暴发以来的最高数字。印度民众21日庆祝疫苗接种突破10亿剂里程碑。印度的疫情虽然相较于高峰期时已经大幅缓和,但是周四公布的新增感染人数(18454人)还是比此前一天高26%。

英国首相约翰逊呼吁民众接种新冠疫苗加强针

近期,英国单日新增新冠肺炎确诊病例持续走高,截至当地时间22号,英国已经连续两天日增确诊病例维持在5万例左右的高位,居于欧洲各国之首,仅次于美国。

英国首相约翰逊表示,这一感染水平仍属预料之内,因此不会实行封锁措施。他还呼吁,为应对疫情,公众应当尽快接种新冠疫苗“加强针”,尤其是50岁以上的人群。目前,在英国12岁以上人群中,已有约80%的人完成两剂疫苗接种,其中数百万人符合接种加强针的资格。

英国政府发布的疫情数据显示,过去7天里,英国的新冠肺炎感染水平上升了17.8%,相关病例可能正在呈指数式增长。专家建议,应当尽早采取应对措施,以免疫情恶化后触发更严格的封锁限制。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1650037, encodeId=d034165003e9d, content=<a href='/topic/show?id=21a496002b' target=_blank style='color:#2F92EE;'>#II期临床研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9600, encryptionId=21a496002b, topicName=II期临床研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=891023951385, createdName=huiwelcome, createdTime=Mon Mar 14 21:25:50 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653216, encodeId=4d951653216e3, content=<a href='/topic/show?id=5b011018e07' target=_blank style='color:#2F92EE;'>#I期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10187, encryptionId=5b011018e07, topicName=I期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc1f24335670, createdName=医生2402, createdTime=Tue Apr 19 03:25:50 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524976, encodeId=6f6515249e6e9, content=<a href='/topic/show?id=4ba395994d' target=_blank style='color:#2F92EE;'>#II期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9599, encryptionId=4ba395994d, topicName=II期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=139811614978, createdName=guihongzh, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526006, encodeId=461c152600643, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063168, encodeId=16611063168d5, content=内容丰富@!!<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a>,不过罗氏的口服治疗新冠的药物失败,真是难以理解,它在体外抗病毒活性更强,但是到体内就不灵了?现在就看开拓药业的,估计也悬。最靠谱的可能是野盐义的了,这个公司开发抗病毒药物一向很厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Oct 23 13:48:33 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063117, encodeId=0cca106311e8f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Sat Oct 23 09:45:47 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063106, encodeId=10021063106f3, content=睡眠障碍可能是导致这种风险的一个未确, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Oct 23 08:52:14 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1650037, encodeId=d034165003e9d, content=<a href='/topic/show?id=21a496002b' target=_blank style='color:#2F92EE;'>#II期临床研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9600, encryptionId=21a496002b, topicName=II期临床研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=891023951385, createdName=huiwelcome, createdTime=Mon Mar 14 21:25:50 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653216, encodeId=4d951653216e3, content=<a href='/topic/show?id=5b011018e07' target=_blank style='color:#2F92EE;'>#I期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10187, encryptionId=5b011018e07, topicName=I期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc1f24335670, createdName=医生2402, createdTime=Tue Apr 19 03:25:50 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524976, encodeId=6f6515249e6e9, content=<a href='/topic/show?id=4ba395994d' target=_blank style='color:#2F92EE;'>#II期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9599, encryptionId=4ba395994d, topicName=II期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=139811614978, createdName=guihongzh, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526006, encodeId=461c152600643, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063168, encodeId=16611063168d5, content=内容丰富@!!<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a>,不过罗氏的口服治疗新冠的药物失败,真是难以理解,它在体外抗病毒活性更强,但是到体内就不灵了?现在就看开拓药业的,估计也悬。最靠谱的可能是野盐义的了,这个公司开发抗病毒药物一向很厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Oct 23 13:48:33 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063117, encodeId=0cca106311e8f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Sat Oct 23 09:45:47 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063106, encodeId=10021063106f3, content=睡眠障碍可能是导致这种风险的一个未确, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Oct 23 08:52:14 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1650037, encodeId=d034165003e9d, content=<a href='/topic/show?id=21a496002b' target=_blank style='color:#2F92EE;'>#II期临床研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9600, encryptionId=21a496002b, topicName=II期临床研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=891023951385, createdName=huiwelcome, createdTime=Mon Mar 14 21:25:50 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653216, encodeId=4d951653216e3, content=<a href='/topic/show?id=5b011018e07' target=_blank style='color:#2F92EE;'>#I期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10187, encryptionId=5b011018e07, topicName=I期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc1f24335670, createdName=医生2402, createdTime=Tue Apr 19 03:25:50 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524976, encodeId=6f6515249e6e9, content=<a href='/topic/show?id=4ba395994d' target=_blank style='color:#2F92EE;'>#II期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9599, encryptionId=4ba395994d, topicName=II期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=139811614978, createdName=guihongzh, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526006, encodeId=461c152600643, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063168, encodeId=16611063168d5, content=内容丰富@!!<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a>,不过罗氏的口服治疗新冠的药物失败,真是难以理解,它在体外抗病毒活性更强,但是到体内就不灵了?现在就看开拓药业的,估计也悬。最靠谱的可能是野盐义的了,这个公司开发抗病毒药物一向很厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Oct 23 13:48:33 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063117, encodeId=0cca106311e8f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Sat Oct 23 09:45:47 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063106, encodeId=10021063106f3, content=睡眠障碍可能是导致这种风险的一个未确, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Oct 23 08:52:14 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1650037, encodeId=d034165003e9d, content=<a href='/topic/show?id=21a496002b' target=_blank style='color:#2F92EE;'>#II期临床研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9600, encryptionId=21a496002b, topicName=II期临床研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=891023951385, createdName=huiwelcome, createdTime=Mon Mar 14 21:25:50 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653216, encodeId=4d951653216e3, content=<a href='/topic/show?id=5b011018e07' target=_blank style='color:#2F92EE;'>#I期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10187, encryptionId=5b011018e07, topicName=I期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc1f24335670, createdName=医生2402, createdTime=Tue Apr 19 03:25:50 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524976, encodeId=6f6515249e6e9, content=<a href='/topic/show?id=4ba395994d' target=_blank style='color:#2F92EE;'>#II期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9599, encryptionId=4ba395994d, topicName=II期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=139811614978, createdName=guihongzh, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526006, encodeId=461c152600643, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063168, encodeId=16611063168d5, content=内容丰富@!!<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a>,不过罗氏的口服治疗新冠的药物失败,真是难以理解,它在体外抗病毒活性更强,但是到体内就不灵了?现在就看开拓药业的,估计也悬。最靠谱的可能是野盐义的了,这个公司开发抗病毒药物一向很厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Oct 23 13:48:33 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063117, encodeId=0cca106311e8f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Sat Oct 23 09:45:47 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063106, encodeId=10021063106f3, content=睡眠障碍可能是导致这种风险的一个未确, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Oct 23 08:52:14 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1650037, encodeId=d034165003e9d, content=<a href='/topic/show?id=21a496002b' target=_blank style='color:#2F92EE;'>#II期临床研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9600, encryptionId=21a496002b, topicName=II期临床研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=891023951385, createdName=huiwelcome, createdTime=Mon Mar 14 21:25:50 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653216, encodeId=4d951653216e3, content=<a href='/topic/show?id=5b011018e07' target=_blank style='color:#2F92EE;'>#I期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10187, encryptionId=5b011018e07, topicName=I期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc1f24335670, createdName=医生2402, createdTime=Tue Apr 19 03:25:50 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524976, encodeId=6f6515249e6e9, content=<a href='/topic/show?id=4ba395994d' target=_blank style='color:#2F92EE;'>#II期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9599, encryptionId=4ba395994d, topicName=II期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=139811614978, createdName=guihongzh, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526006, encodeId=461c152600643, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063168, encodeId=16611063168d5, content=内容丰富@!!<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a>,不过罗氏的口服治疗新冠的药物失败,真是难以理解,它在体外抗病毒活性更强,但是到体内就不灵了?现在就看开拓药业的,估计也悬。最靠谱的可能是野盐义的了,这个公司开发抗病毒药物一向很厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Oct 23 13:48:33 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063117, encodeId=0cca106311e8f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Sat Oct 23 09:45:47 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063106, encodeId=10021063106f3, content=睡眠障碍可能是导致这种风险的一个未确, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Oct 23 08:52:14 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
    2021-10-23 病毒猎手

    内容丰富@!!#疫情#,不过罗氏的口服治疗新冠的药物失败,真是难以理解,它在体外抗病毒活性更强,但是到体内就不灵了?现在就看开拓药业的,估计也悬。最靠谱的可能是野盐义的了,这个公司开发抗病毒药物一向很厉害

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1650037, encodeId=d034165003e9d, content=<a href='/topic/show?id=21a496002b' target=_blank style='color:#2F92EE;'>#II期临床研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9600, encryptionId=21a496002b, topicName=II期临床研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=891023951385, createdName=huiwelcome, createdTime=Mon Mar 14 21:25:50 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653216, encodeId=4d951653216e3, content=<a href='/topic/show?id=5b011018e07' target=_blank style='color:#2F92EE;'>#I期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10187, encryptionId=5b011018e07, topicName=I期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc1f24335670, createdName=医生2402, createdTime=Tue Apr 19 03:25:50 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524976, encodeId=6f6515249e6e9, content=<a href='/topic/show?id=4ba395994d' target=_blank style='color:#2F92EE;'>#II期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9599, encryptionId=4ba395994d, topicName=II期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=139811614978, createdName=guihongzh, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526006, encodeId=461c152600643, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063168, encodeId=16611063168d5, content=内容丰富@!!<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a>,不过罗氏的口服治疗新冠的药物失败,真是难以理解,它在体外抗病毒活性更强,但是到体内就不灵了?现在就看开拓药业的,估计也悬。最靠谱的可能是野盐义的了,这个公司开发抗病毒药物一向很厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Oct 23 13:48:33 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063117, encodeId=0cca106311e8f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Sat Oct 23 09:45:47 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063106, encodeId=10021063106f3, content=睡眠障碍可能是导致这种风险的一个未确, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Oct 23 08:52:14 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
    2021-10-23 ms4000000654879381

    学习啦

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1650037, encodeId=d034165003e9d, content=<a href='/topic/show?id=21a496002b' target=_blank style='color:#2F92EE;'>#II期临床研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9600, encryptionId=21a496002b, topicName=II期临床研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=891023951385, createdName=huiwelcome, createdTime=Mon Mar 14 21:25:50 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1653216, encodeId=4d951653216e3, content=<a href='/topic/show?id=5b011018e07' target=_blank style='color:#2F92EE;'>#I期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10187, encryptionId=5b011018e07, topicName=I期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc1f24335670, createdName=医生2402, createdTime=Tue Apr 19 03:25:50 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524976, encodeId=6f6515249e6e9, content=<a href='/topic/show?id=4ba395994d' target=_blank style='color:#2F92EE;'>#II期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9599, encryptionId=4ba395994d, topicName=II期临床)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=139811614978, createdName=guihongzh, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526006, encodeId=461c152600643, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Sun Oct 24 23:25:50 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063168, encodeId=16611063168d5, content=内容丰富@!!<a href='/topic/show?id=ec54e04707a' target=_blank style='color:#2F92EE;'>#疫情#</a>,不过罗氏的口服治疗新冠的药物失败,真是难以理解,它在体外抗病毒活性更强,但是到体内就不灵了?现在就看开拓药业的,估计也悬。最靠谱的可能是野盐义的了,这个公司开发抗病毒药物一向很厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70470, encryptionId=ec54e04707a, topicName=疫情)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Oct 23 13:48:33 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063117, encodeId=0cca106311e8f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=994a5643790, createdName=ms4000000654879381, createdTime=Sat Oct 23 09:45:47 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063106, encodeId=10021063106f3, content=睡眠障碍可能是导致这种风险的一个未确, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Sat Oct 23 08:52:14 CST 2021, time=2021-10-23, status=1, ipAttribution=)]
    2021-10-23 查查佳佳

    睡眠障碍可能是导致这种风险的一个未确

    0

相关资讯

2021年10月5日简报:欧洲药管局批准所有成人打辉瑞加强针;卡塔尔将中国新冠疫苗列入认可疫苗清单;英国进一步简化入境政策

截至北京时间2021年10月5日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23606万例,新增307,395例,达到236,062,47

2021年10月20日简报:本土多省份出现少量病例感染,多省严格管控;FDA将允许民众混打不同品牌新冠疫苗加强针;英国疫情反弹,但是死亡维持在低水平

截至北京时间2021年10月20日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4228万例,新增397,761例,达到242,286,

2021年10月10日简报:年底时可能有多款新冠病毒治疗口服药问世;安徽、福建、湖北、黑龙江、海南、广西、浙江、河南等地启动加强针;新西兰正式宣布同新冠共存

截至北京时间2021年10月10日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过238327万例,新增347,076例,达到238,327,

医学英语:WHO警告新冠疫情可能会持续至2022年末

世界卫生组织表示,由于贫穷国家无法获得所需疫苗,新冠疫情很可能将持续到2022年末。目前非洲的疫苗接种率仅为5%,而其他大陆的疫苗接种率基本都达到了40%。

2021年10月19日简报:本土又有少量病例感染;中国今年生产60亿剂疫苗,达到全球一半;混合接种加强针效果可能更好;

截至北京时间2021年10月19日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4144万例,新增292,704例,达到241,446,

2021年10月17日简报:国内20余省开打加强针;阿联酋巴林接种中国疫苗为主,疫情控制良好;俄罗斯,英国疫情仍然在上升;日本疫情快速退潮;

截至北京时间2021年10月17日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4114万例,新增338,388例,达到241,145,

Baidu
map
Baidu
map
Baidu
map